San Francisco – TAZI AI, a fast-growing Artificial Intelligence (AI) company with offices in San Francisco, Chicago, and Istanbul, recently agreed to develop a project with Novartis Turkey, one of Turkey’s leading pharmaceutical companies.
Within this scope, Novartis and TAZI AI aim to contribute positively to health services through creating innovative solutions which will address the obstacles in the patient’s journey.
Novartis Turkey’s Health Solutions Unit Manager Dr. Murat Aşık: “Machine Learning algorithms such as Data Science and Artificial Intelligence have started transforming healthcare. We think stakeholders who can integrate these solutions into their business processes and offer innovative solutions to patients will be one step ahead in the fight against diseases. As Novartis, we are one of the leading pharmaceutical companies focusing on this field. All over the world, our goal is to contribute to better medical service delivery with the power of advanced therapy platforms, data science, and digital technologies. In this context, we cooperate with TAZI AI, an expert in AI solutions. With this cooperation, we will continue our efforts to improve public health by using big data in different disease areas. We believe that the effective use of data by making it meaningful in the fight against diseases will be among the future health trends. As Novartis, we want to put forward useful projects by including patients, healthcare professionals, and healthcare systems in our digital transformation journey.”
TAZI AI Global Pharma & Healthcare Lead Sandra Lopez Claveria added, “…. Today, heart disease remains the leading cause of death worldwide. We are privileged to work hand in hand with Novartis in Turkey to predict, help prevent and manage this fatal disease. By combining our AI technology with Novartis’ treatment diseases expertise, we can make a difference, alleviating the burden on the healthcare systems while helping healthcare practitioners improve their patients’ lives.”
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 800 million people globally, and we are finding innovative ways to expand access to our latest treatments. About 108,000 people of more than 140 nationalities work at Novartis worldwide.
Find out more at www.novartis.com.
About TAZI AI
Founded in May 2015, TAZI AI is a leading AI software company with a vision to ensure that machine learning (ML) serves every person. TAZI AI provides easy-to-use, no-code, transparent ML solutions based on its proprietary AutoML platform. TAZI AI is headquartered in San Francisco. You can learn more about TAZI AI on www.tazi.ai.
For more information please contact: